Exposure to polycylic aromatic hydrocarbons (PAH) has been associated with increased risk of lung cancer. Aryl hydrocarbon receptor (AhR) is known to play an essential role in PAH-induced toxicity. The objectives of this study were to identify and evaluate AhR expression in normal human lung tissues and in lung carcinomas. AhR protein and mRNA levels in human lung cell lines were evaluated with immunoblot and quantitative real-time RT-PCR assays, respectively. AhR protein expression was high in cytosol homogenates of adenocarcinoma (AD) cell lines and AhR mRNA levels corresponded well with AhR protein levels in these cell lines. AhR expression in human lung tissues and carcinomas were examined by means of immunohistochemical staining method. In normal lung tissues, immunostaining was found in the cytosol of bronchiolar epithelial cells. AhR immunostaining was more intense in AD than in squamous cell carcinomas. When AhR expression was compared with normal bronchiolar epithelial cells and neoplastic cells in the same specimens, the neoplastic cells, especially those of AD, demonstrated an increased staining. The upregulation of AhR mRNA expression was also demonstrated among 2 of 4 paired tissues with the quantitative real-time RT-PCR assay. Our data indicated that AhR expression was upregulated in lung AD and suggested that AhR and its expression might play an important role in the development of lung AD.
INTRODUCTION
Lung cancer is the leading cause of cancer death worldwide (23) . Epidemiological studies suggest that exposure to environmental pollutants, such as environmental tobacco smoke, polycyclic aromatic hydrocarbons (PAH), contaminated air pollutants, and 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD), contributes to the development of lung cancers (3, 16, 22) . Benzo[a]pyrene (B[a]P) is the major PAH found in environmental tobacco smoke and air pollutants. Both B[a]P and TCDD increase the incidence of lung tumors in rodents (12, 15) . B[a]P is known to be metabolized into carcinogenic metabolites, which directly attack DNA. By contrast, TCDD and its metabolites are not known to be genotoxic. The molecular mechanism by which TCDD induces carcinogenesis remains unclear.
Although the mechanisms of B[a]P and TCDD-induced lung carcinogenesis may be different, they share the same receptor, aromatic hydrocarbon receptor (AhR). AhR is a transcription factor of the basic helix-loop-helix/Per-Arnt-Sim family (36) . AhR activation is dependent on ligand binding. PAH and halogenated aromatic hydrocarbons are AhR ligands, among which TCDD is the most potent. The liganded AhR translocates to the nuclei, heterodimerizes with AhR nuclear translocator, binds to the cognate enhancer sequence, and subsequently transactivates downstream gene expression (36) . AhR regulates genes code for xenobiotic metabolizing enzymes, such as cytochrome P4501A1 (CYP1A1), cytochrome P4501B1 (CYP1B1), and growth-regulatory proteins (25) . Several studies have demonstrated that AhR activation is required for B[a]P and TCDD-induced toxicity (7, 29) . AhR mRNA was abundantly expressed in lung (9) . Furthermore, Tritscher et al (32) demonstrated that AhR protein expresses in lung epithelial cells and TCDD exposure induces alveolar-bronchiolar metaplasia in the lung. Thus, AhR may also play an important role in the molecular mechanism of B[a]P and TCDD induced lung carcinogenesis. Despite this, AhR protein expression in human lung tissues and lung tumors has never been investigated.
Adenocarcinoma (AD) and squamous cell carcinoma (SQ) are 2 major histological types of lung cancers in Taiwan (5) . Although most SQs arise from the centrally located bronchial epithelium, AD occurs in the bronchiolar epithelium of the peripheral airway. It has been reported that cigarette smoking is more strongly associated with SQ than AD (8) . Several carcinogenic PAH compounds found in cigarette smoke are metabolically activated by CYP1A1. For example, CYP1A1 is known to convert B[a]P into BaP-7,8-oxide, which is further metabolized to (-)trans7,8-dihydroxy7,8dihydrobenzo[a]pyrene, forming DNA adducts (6, 28) . If the resultant DNA damage is not properly repaired, mutation may occur, leading to carcinogenesis. Kouri et al (17) and our previous study (20) reported that CYP1A1 inducibility and genetic polymorphism were associated with the risk of lung SQ. However, Anttila et al (1) demonstrated that CYP1A1 expression was higher in the peripheral lung carcinomas than in SQ. Similarly, Saarikoski et al (26) found that CYP1A1 mRNA and protein are mainly located in the bronchiolar epithelium of the peripheral lung where AD arises. These results contradict the claim that AD is less common in cigarette smokers 22 0192-6233/03$3.00+$0.00 Vol. 31, No. 1, 2003 AhR IN LUNG ADENOCARCINOMA 23 (8) . Therefore, the mechanism of cell type-specific CYP1A1 expression deserves further study. As previously described, CYP1A1 gene expression is regulated by the AhR signaling pathway. It is possible that cell type-specific CYP1A1 expression in lung tissues is mediated by AhR expression. Thus, further investigation is needed into the identification and localization of AhR in lung tissues and AhR expression in normal vs cancer-bearing lung tissues. Our present study throws light on the identification and localization of AhR in normal lung tissues and in lung cancers. AhR expression in these tissues will be evaluated and compared. We believe that the results of our present investigation will serve to further elucidate the relationship between AhR and lung cancer development in humans.
MATERIALS AND METHODS
Cell Culture: Seven human lung cancer cell lines, 4 AD cells NCI-H1355, NCI-H23, CL3, and CL5, and 3 SQ cells NCI-H226, CH27, and Calu-1, were studied. NCI-H1355, NCI-H23 and NCI-H226 were gifts from Dr. C.-M. Tsai (Veterans General Hospital-Taipei, Taiwan, ROC). Information for NCI-H1355, NCI-H23, NCI-H226, and Calu-1 was available in American Type Cell Collection (Manassas, VA). CH27 cells were gift from Dr. S.-L. Hsu (Veterans General Hospital-Taichung, Taiwan, ROC) and derived from lung squamous cell carcinoma (11) . CL3 and CL5 cells were from Dr. P.-C. Yang (National Taiwan University, Taiwan, ROC). CL3 cells were derived from a lung adenocarcinoma tumor specimen of a 60-year-old male patient at the Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan (19) . CL5 cells were derived from a lung adenocarcinoma tumor specimen of a 40-year-old female patient at the Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan (34) . NCI-H1355, H23, H226, CH27, and CL5 cells were maintained in RPMI 1640 supplemented with 5% heat-inactivated fetal bovine serum. Calu-1 cells were maintained in McCoy's 5A medium supplemented with 10% heat-inactivated fetal bovine serum. CL3 cells were maintained in F-12 medium supplemented with 10% heat-inactivated fetal bovine serum. BEAS-2B cells were human bronchial epithelial cell lines immortalized with SV40 (American Type Culture Collection, Manassas, VA) and maintained in LHC-9 medium.
Western Immunoblot Analysis: The cell homogenates were prepared and analysed with Western blot as previously described (4) . The AhR and the β-actin antibodies were from Biomol (Plymouth Meeting, PA) and from Sigma (Saint Louis, MO) respectively. Bands were visualized using an enhanced chemiluminescence kit according to instructions from the manufacturer (Amersham, Buckinghamshire, UK).
Quantitative Real-Time Reverse Transcription-Polymerase Chain Reaction (RT-PCR) Assay:
Total RNAs of cells and tissues were prepared by TRI ZOL Reagent (Life Technologies, Rockville, MD) and the phenol-chloroform extraction method. Synthesis of cDNA was done with 2 µg total RNA using M-MLV Reverse Transcriptase (Promega, Madison, WI). Quantitative PCR was performed using the QuantiTect SYBR Green PCR kit (Qiagen, Hilden, Germany) and analyzed on a ABI PRISM 7700 Sequence Detector System (Perkin-Elmer Applied Biosystem, Foster City, CA). Primers were chosen with the assistance of the computer program-Primer Express (Perkin-Elmer Applied Biosystem, Foster City, CA). To avoid amplification of contaminating genomic DNA, 1 of the 2 primers was placed at the junction between two exons. AhR primers are 5 -acatcacctacgccagtcgc and 5 -tctatgccgcttggaaggat. β-actin primers are 5 -tcatgaagtgtgacgtggacatc and 5caggaggagcaatgatcttgatct. The optimal primer concentrations for AhR and β-actin were respectively 400 and 100 nM. The thermal cycling comprised an initial step at 50 • C for 2 minutes, followed by a denaturation step at 95 • C for 10 min, 40 cycles at 95 • C for 15 seconds and 40 cycles at 60 • C for 1 minute. Varying lengths of oligonucleotides produce dissociation peaks at different melting temperatures. Consequently, at the end of the PCR cycles, the PCR products were analyzed using heat dissociation protocol to confirm that 1 single PCR product was detected by SYBR Green dye. Each data point was repeated 4 times. Quantitative values were obtained from the threshold PCR cycle number (C T ) at which the increase in signal associated with an exponential growth for PCR product starts to be detected. The AhR expression level in each sample was normalized to its β-actin content. Final results, expressed as fold changes in tumor AhR gene expression in tumors, relative to that of nontumor tissues, were determined as follows:
Patient Samples: This project was approved by the Human Subjects Committee in Chung Shan Medical University Hospital, Taichung, Taiwan. A panel of 85 primary lung cancer specimens including 4 small cell carcinomas, 54 AD, 31 SQ, 4 large cell carcinomas, and 2 adenosquamous cell carcinoma were examined in the present study. Specimens of small cell lung carcinoma were obtained by bronchoscopic or needle biopsies. Normal lung tissues were obtained from 7 autopsies, 1 taken from patient with metastatic prostate cancer and 1 taken from patient with metastatic breast cancer. One fetal lung was obtained from a fetus with a gestational age of 24 weeks that was artificially aborted because of a congenital anomaly found in routine sonographic examinations. Surgical specimens were fixed in 10% neutral-buffered formalin and then embedded in paraffin. Fresh tissues were directly stored at −70 • C until RNA isolation.
Immunohistochemistry: Immunohistochemical staining was performed on paraffin-embedded tissue using the LSAB Kit (Dako, Glostrup, Denmark) and the DAB-plus substrate kit (Zymed, San Francisco, CA). Tissue sample sections included tumor and nontumor areas. Tissue sections (4-5 mm) were immersed in 3% hydrogen peroxide for 15 minutes to block endogenous peroxidase activity, then microwaved in 0.01 M citrate buffer (pH 6.0) for 3 × 5 minutes. After washing, the sections were incubated at 4 • C overnight with AhR antibody (1:90 dilution; from Biomol, Plymouth Meeting, PA), followed by a standard staining procedure using the LSAB kit (Dako, Glostrup, Denmark). 24 
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Evaluation of Immunostaining: The AhR expression in cells was measured with an AhR immunostaining technique. To guard against false positive or false negative staining, a positive control was used in all our staining procedures. Cells in the basal layer of the prostate gland were known to be rich in AhR (13) . Thus, human hyperplastic prostate sections were used as positive controls in our study. Furthermore, to nullify variations in staining intensity due to variances in thicknesses between tissue sections, vascular smooth muscle cells, which showed a consistent medium level of AhR expression, in each section examined were used as an internal control. All immunostaining was graded by 3 independent blinded observers (H. Chang, W.-T. Tsai, and M.-H. Wu); at least 100 cells were counted and evaluated per specimen. Final grades were derived by averaging the gradings from these observers. Each specimen was defined as a high AhR expresser or low AhR expresser by the immunostaining intensity of the tumor cells examined. A specimen was defined as high AhR expresser when most cells in the specimen were more intensely stained than the internal control cells. A specimen was regarded as low AhR expresser if most cells demonstrated the same or less staining intensity than the internal control cells.
The images of immunostained cells were obtained with 100 times enlargement through a 3-CCD color video camera (JVC KY-F55BU, JVC). AhR immunostaining intensity in the obtained digital images was quantified with Image Pro Plus 3.0 image analysis program (Media Cybernetic, Inc, Silver Spring, MD). This method was also used to confirm the grading and to compare the immunostaining intensity between tumor cells and adjacent normal epithelial cells.
Statistical Analysis: Pearson's chi-square test was used to examine the difference in AhR expression between AD and SQ. Fisher's exact test was used to examine the difference in the prevalence of increased AhR expression between AD and SQ.
RESULTS
The linear range of the quantitative real-time RT-PCR assay was determined by amplifying serial dilutions of cDNA. The cDNA from human lung AD cells H1355 was mixed with 0.01 ng/ml AhR expression plasmid (gift from Dr. C. A. Bradfield). The standard curve was examined by amplifying 5-fold serial dilutions of the cDNA mixture using primers for AhR and β-actin. The amplification was linear when C T was 35 to 21 for AhR or 30 to 16 for β-actin. (Figure 1A) . The standard curve is plotted by the log of the template dilution fold vs the C T . As shown in Figure 1B , the slope of the C T(AhR−β-actin) is −0.01, which indicated that the amplification efficiency of AhR and β-actin genes was equal.
AhR mRNA levels in the 7 lung cancer cell lines and human bronchial cell lines BEAS-2B were quantified with the quantitative real-time RT-PCR assay. The AhR expression level in each sample was normalized to its β-actin content. As shown in Figure 2A , AhR relative mRNA levels in AD cells (H1355, CL3, and CL5 cells) were at least 2-fold of levels in BEAS-2B cells. But AhR relative mRNA levels in SQ cells (Calu-1, H226, and CH27 cells) were lower than that of BEAS-2B cells. When AhR levels were normalized with the levels of glyceraldehyde-3-phosphate dehydrogenase, the results were similar (data not shown). AhR protein expression in the cell homogenates of these cell lines was also examined using Western blot analysis. The specificity of anti-AhR was confirmed by detecting a single band of approximately 100-110 kDa protein in the cell homogenates of mouse lung and H1355 cells ( Figure 2B ). Consistent with AhR mRNA levels, AhR protein levels in H1355, CL3, and CL5 cells were higher than the average level of these 8 cell lines ( Figure 2C and 2D). Nevertheless, AhR protein levels in Calu-1, H226, and CH27 cells were lower than the average level ( Figure 2C and 2D).
AhR protein expression levels and locations were examined with immunohistostaining method in 10 nontumor lung specimens (1 from fetal lung tissue and 9 from normal adult lung tissue) and 95 lung tumors. The immunoreactivity of anti-AhR in these tissues is summarized in Table 1 and the representative photos were presented in Figure 3 .
The hyperplastic prostate section was used as a positive control ( Figure 3A) . In all of the specimens examined, high immunostaining was primarily located in the cytosol of bronchiolar epithelial cells ( Figure 3C ). Other cell types, such as bronchial epithelial cells, showed weak or no staining activity ( Figure 3B 5 male nonsmokers, 2 male smokers, and 2 female nonsmokers (data not shown). AhR expression was high in bronchiolar epithelium of all females and smokers (data not shown). In general, fetal tissue presented a weaker AhR staining than adult tissues. AhR is highly expressed in small cell lung cancers and AD ( Figure 3E and 3G) . AhR expression was low in the cytosol of large cell carcinoma ( Figure 3H ). Furthermore, high expression of AhR was more common in AD (42 of 54) than in SQ (16 of 31) ( Figure 3F ) ( p < 0.05).
To understand whether this discrepancy occurred between tumor and nontumor areas of the same specimens, AhR immunostaining intensity was examined in 54 AD and 31 SQ. AhR immunostaining intensity in the cytosol of tumor cells and adjacent normal bronchiolar epithelial cells within the same section was quantified and compared with an image analysis program Image Pro Plus as described in Methods. Overexpression was defined as the immunostaining intensity in tumor cells higher than in adjacent bronchiolar epithelial cells within the same slide (Figure 4 ). Quantification results of AhR overexpression in 26 specimens were listed in Table 2 . For AhR overexpressed specimens, the intensity ratio of tumor cells versus bronchiolar epithelial cells was greater than 1 ( Table 2) . For nonoverexpressed specimens, the ratio was less than 1 (data not shown). As shown in Table 3 , AhR expression in neoplastic cells was increased among 26 out of 85 (30.6%) specimens. Of these, increased expression of AhR was more common in AD (42.6%, 23/54, Figure 3 ) than in SQ (9.7%, 3/31) ( p < 0.01). Gender and smoking status have no significant effect on the increase of AhR (Table 3) . Nontumor-bearing tissues 2-4 cm adjacent from the tumors were sampled surgically to serve as paired controls. The relative levels of AhR mRNA were quantified in 4 specimens and their paired control tissues devoid of cancer cells with the quantitative real-time RT-PCR assay. The data were calculated and presented according to the method described in Materials and Methods. In Table 4 , patients number 3, 4, and 11 were AD and number 22 was SQ. AhR mRNA levels in 2 of 4 lung tumors were increased to approximately 2-fold of the levels in the paired nontumor tissues (Table 4 ). However, the increase was not significant when the data was analyzed with paired Student's t-test ( p = 0.11, data not shown). As compared with immunostaining data, only 1 of 4 specimens correlated with increased AhR protein and mRNA level (data not shown). -AhR immunostaining patterns of the prostate, normal lung tissues, and lung tumors. Tissue sections were stained with anti-AhR and the reactivity was visualized as brown color by DAB as described in Materials and Methods. Magnifications for the photomicrographs are shown in parentheses. A) Benign hyperplastic prostate (×400). The positive immunostaining was present at the basal cells of prostatic glands and served as a positive control. B) Normal bronchus (×200). The bronchial epithelium showed low AhR expression, consistent with low AhR expression in smooth muscle cells of bronchial walls or vessels. C) Normal bronchiole (×400). The bronchiolar epithelium showed high AhR expression. D) Lung parenchyma (×400). Negative AhR immunostaining occurred in type I and II pheumocytes. E) AD (×400). The cytoplasm of tumor cells had high AhR staining activity. F) SQ (×400). The cytosol of most tumor cells had low AhR staining activity. G) SCLC (×400). AhR immunointensity in the cytosol and nuclei of tumor cells was high. H) Large cell carcinoma (×400). Minimal AhR immunostaining was found in the cytoplasm of tumor cells.
DISCUSSION
There is ample evidence that AhR mediates CYP1A1 induction by PAH (25) . It has been reported that human CYP1A1 is mainly located in the bronchiolar epithelium of human lung tissues (1, 26) . It is of interest to note that AhR in the lungs is primarily located in the bronchiolar epithelial cells, while an increased staining intensity was found in the neoplastic cells. Although AhR staining could also be detected in smooth muscle cells and bronchial epithelial cells, AhR expression in these cells was relatively weak. The localization of AhR is consistent with that of CYP1A1 reported by Anttila et al (1) and Saarikoski et al (26) . This agreement further supports the accuracy of AhR localization in lung tissues reported in our present study. Our present study represents the first report of a direct and positive correlation between AhR 28 LIN ET AL TOXICOLOGIC PATHOLOGY localization and upregulation of AhR expression in lung cancer development.
It has been demonstrated that AhR mRNA and protein levels were elevated in 7,12-dimethylbenzo[a]anthraceneinduced rat mammary tumors (33) . In the present study, we also observed an elevation of AhR protein in lung AD. In addition, AhR protein expressions in 2 of 4 AD cell lines were higher than those in bronchial epithelial cells BEAS-2B and SQ cell lines. AhR protein levels in cell lines corresponded well with the relative mRNA levels. However, the correlation between the increase in AhR protein and RNA was poor in 4 paired specimens. AhR protein expression may be regulated in conjunction with PAH-induced carcinogenesis. It is also possible that AhR is upregulated in AD regard- The mRNA levels were determined with the quantitative real-time RT-PCR assay. Each measurement was repeated 4 times. less of PAH exposure. More evidences are needed to understand the relationship between upregulation of AhR and PAH exposure.
There was a report claiming that the relative risk of AD for smokers was comparatively lower than that of SQ (8) . In our study subjects, approximately 50% of SQ were smokers, nevertheless, only 11% of AD were smokers (data not shown). Our present finding that SQ development is more closely associated with cigarette smoking whereas AD is predominantly found in nonsmokers is consistent with other reports in the literature (8) . Our study also demonstrated that AhR was primarily located in the bronchiolar epithelium of normal lung tissues. This observation was consistent with the study by Tritscher et al that TCDD induced alveolar-bronchiolar metaplasia in female rats (32) . These observations suggest that AhR and its expression may be associated with adenocarinoma development.
Association between CYP1A1 and lung cancer risk among smokers is still controversal (14, 24, 31, 35) . Anttila et al (1) and Saarikoski et al (26) reported that CYP1A1 mRNA and protein expressions were more intense in smokers with AD than in smokers with SQ. Our present study also demonstrated that AhR expression was more up regulated in AD than in SQ (Table 2) , corresponding well with the upregulation of CYP1A1 expression in AD as reported by Anttila et al (1) and Saarikoski et al (26) . In our present study approximately 50% of SQ cases were smokers (data not shown), but only 9.4% of SQ cases demonstrated upregulation of AhR ( Table 2 ). The relationship between AhR and SQ development in smokers requires further investigation. Small cell lung cancers (SCLC) are known to be strongly associated with cigarette smoking (2) . In the present study 3 of 4 SCLC specimens showed intense AhR expression (Table 1 ). However, because of the small sample size used in this study, this observation will have to be confirmed with further investigation.
Similar to CYP1A1, gene expression of CYP1B1 was inducible by TCDD (18) . It suggests that AhR regulates CYP1B1 expression. CYP1B1 does not only metabolically activate PAH, but also converts estrogens into carcinogenic metabolites (10, 27) . CYP1B1 expression has been reported in various types of malignant tumors, such as cancers of the breast, colon, lung, esophagus, brain, and testis (21) . Recent work by Spivack et al (30) demonstrated that the level of CYP1B1 mRNA and protein was significantly higher in human lung cancers than in nonturmor tissues. Unliganded AhR was present in the cytosol associated with heat shock protein Vol. 31, No. 1, 2003 AhR IN LUNG ADENOCARCINOMA 29 90 (25) . Overexpression of cytosolic AhR may increase the responsiveness of the cells to ligands and enchance the induction of AhR-regulated downstream gene expression, such as CYP1B1. Therefore, upregulation of AhR in lung tumors reported from our present study may explain the elevation of CYP1B1 in lung tumors reported by Spivack et al (30) . The interrelationship between AhR and CYP1B1 expression in lung tumors is under investigation in our laboratory. It is well recognized that AhR plays an important role in PAH and TCDD-induced toxicity. Although exposure to PAH and TCDD is suspected to induce lung cancer, there is little in the literature on the role of AhR in toxicant-induced lung tumors. Our present study provides the evidence that AhR is up regulated in lung AD. Further investigation is necessary to define the mechanism and biological significance of elevated AhR expression in lung carcinogenesis.
